271.Bermejo J, Yotti R, García-Orta R, et al. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. Eur Heart J 2018; 39(15): 1255–1264.
272.Skoro-Sajer N, Marta G, Gerges C, Hlavin G, Nierlich P, Taghavi S, Sadushi-Kolici R, Klepetko W, Lang IM. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy// Thorax. - 2014.-Vol.69.-N.2-P.116–122.
273.Jenkins D, Madani M, Fadel E, D'Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017; 26(143): pii: 160111.
274.Jenkins DP, Biederman A, D'Armini AM, Dartevelle PG, Gan HL, Klepetko W, Lindner J, Mayer E, Madani MM. Operability assessment in CTEPH: Lessons from the CHEST-1 study. J Thorac Cardiovasc Surg. 2016; 152(3):669–674.
275.Madani M, Ogo T, Simonneau G. The changing landscape of chronic thromboembolic pulmonary hypertension management. Eur Respir Rev. 2017; 26(146). pii: 170105.
276.Kataoka M, Inami T, Kawakami T, Fukuda K, Satoh T. Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective. JACC Cardiovasc Interv. 2019; 12(14):1382–1388.
277.Ghofrani HA, D’Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, Mayer E,
Simonneau G, Wilkins MR, Fritsch A, Neuser D, Weimann G, Wang C. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension// N Engl J Med.- 2013 Vol.369.-N4.-P.319–329.
278.Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, Tatebe S, MiyamichiYamamoto S, Shimokawa H. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-termprognosis in patients with chronic thromboembolic pulmonary hypertension// Circ J.- 2012.-Vol.76.-N2.-P.485–488.
279.Sliwa K, van Hagen IM, Budts W, et al. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail. 2016; 18 (9): 1119–28.
280.Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39: 3165– 3241.
281.Makino Y, Matsuda Y, Mitani M, et al. Risk factors associated with preterm delivery in women with cardiac disease. J Cardiol 2012; 59: 291–298.
141
282.Диагностика и лечение сердечно-сосудистых заболеваний при беременности 2018.
Национальные рекомендации. Российский кардиологический журнал 2018, 3 (155):
91–134.
283.Pijuan-Domenech A, Galian L, Goya M, Casellas M, Merced C, Ferreira-Gonzalez I, Marsal-Mora JR, Dos-Subira L, Subirana-Domenech MT, Pedrosa V, Baro-Marine F, Manrique S, Casaldaliga-Ferrer J, Tornos P, Cabero L, Garcia-Dorado D. Cardiac complications during pregnancy are better predicted with the modified who risk score. Int J Cardiol 2015; 195:149–154.
284.Vigl M, Kaemmerer M, Niggemeyer E, Nagdyman N, Seifert-Klauss V, Trigas V, Bauer U, Schneider KT, Berger F, Hess J, Kaemmerer H. Sexuality and reproductive health in women with congenital heart disease. Am J Cardiol 2010; 105:538–541.
285.Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009; 30:256– 265.
286.Roos-Hesselink JW, Budts W, Walker F, De Backer JFA, Swan L, Stones W, Kranke P, Sliwa-Hahnle K, Johnson MR. Organisation of care for pregnancy in patients with congenital heart disease. Heart 2017; 103:1854–1859.
287.Olsson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev.
2016; 25: с.431–437.
288.Olsson KM, Jais X. Birth control and pregnancy management in pulmonary hypertension.
Semin Respir Crit Care Med 2013; 34: с.681–688.
289.Hsu CH, Gomberg-Maitland M, Glassner C, et al. The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients. Int J Clin Pract Suppl 2011; 175: 6–14.
290.Chandrasekhar S, Cook CR, Collard CD. Cardiac surgery in the parturient. Anesth Analg. 2009; 108: 777–785.
291.Ireland LD, Gatter M, Chen AY. Medical compared with surgical abortion for effective pregnancy termination in the first trimester. Obstet Gynecol 2015; 126:22–28.
292.Hemnes A.R., Kiely D.G., Cockrill B.A. et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ 2015; 5: 435– 465.
293.Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA 2016; 316:952–961.
142
294.Kelaranta A, Kaasalainen T, Seuri R, Toroi P, Kortesniemi M. Fetal radiation dose in computed tomography. Radiat Prot Dosimetry 2015; 165:226–230.
295.Jais X, Olsson KM, Barbera JA, et al. Pregnansy outcomes in pulmonary arterial hypertension in the modern management era. EurRespir J 2012; 40: 881–885.
296.Treinen KA, Louden C, Dennis MJ, et al. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. Teratology 1999; 59: с.51–59.
297.Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. 2015 RCOG Green-top Guideline No. 37a
298.Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005; 106:401–407.
299.Terek D, Kayikcioglu M, Kultursay H, et al. Pulmonary arterial hypertension and pregnancy. J Res Med Sci 2013; 18: с.73–76.
300.Madden BP. Pulmonary hypertension and pregnancy. Int J Obstet Anesth 2009; 18: 156– 164.
301.Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M et al. Definitions and Diagnosis of Pulmonary Hypertension. J Am Coll Cardiology 2013; 24;62(25 Suppl): D42–50.
302.Duarte AG, Thomas S, Safdar Z, et al. Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience. Chest 2013; 143:1330–1336.
303.Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: с.1133–1137.
304.Баутин А. Е., Якубов А. В., Коконина Ю. А., Ильин А. Б., Ли О. А., Иртюга О. Б., Мазурок В. А., Зазерская И. Е., Моисеева О. М. Анестезиологическое обеспечение и интенсивная терапия в периоперационном периоде абдоминального родоразрешения у беременных с легочной артериальной гипертензией. Анестезиология и реаниматология 2016; №6: 455–461.
305.Hill W., Holy R., Traiger G. EXPRESS: Intimacy, Contraception, and Pregnancy Prevention in Patients with Pulmonary Arterial Hypertension: Are We Counseling Our Patients? Pulm Circ. 2018 Jun 12.
306.Thorne S, Nelson-Piercy C, MacGregor AJ, et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam PlannReprod Health Care 2006; 32:75–81.
143
307.Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366:2257–2266.
308.Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: National follow-up study. BMJ 2009; 339:b2890.
309.Mantha S, Karp R, Raghavan V, et al. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012; 345: e4944.
310.Vieira CS, Ferriani RA, Garcia AA, Pintao MC, Azevedo GD, Gomes MK, Silvade-Sa MF. Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade. Hum Reprod 2007; 22:2196–2201.
311.Roos-Hesselink JW, Cornette J, Sliwa K, Pieper PG, Veldtman GR, Johnson MR. Contraception and cardiovascular disease. Eur Heart J 2015; 36:1728–1734.
312.Cheng L, Che Y, Gulmezoglu AM. Interventions for emergency contraception. Cochrane Database Syst Rev 2012; 8:CD001324.
313.Vasilakis C, Jick SS, Jick H. The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception 1999; 59:79–83.
314.Gemzell-Danielsson K, Rabe T, Cheng L. Emergency contraception. Gynecol Endocrinol 2013; 29:1–14.
315.Jesam C, Cochon L, Salvatierra AM, Williams A, Kapp N, Levy-Gompel D, Brache V. A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate. Contraception 2016; 93:310–316.
316.Nickel N, Golpon H, Greer M et. Al The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 39:589–596.
317.Barst RJ, Chung L, Zamanian RT et al. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry. Chest 2013; 144:160–168.
318.Bustamante-Labarta M, Perrone S, De La Fuente RL, Stutzbach P, De La Hoz RP, Torino A, Favaloro R. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. J Am Soc Echocardiogr 2002; 15:1160–1164.
319.Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, Chamera E, Corretti MC, Champion HC, Abraham TP, Girgis RE, Hassoun PM. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006; 174:1034–1041.
144
320.Shimada YJ, Shiota M, Siegel RJ, Shiota T. Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study. J Am Soc Echocardiogr 2010; 23: 943–953.
321.Smith BC, Dobson G, Dawson D, Charalampopoulos A, Grapsa J, Nihoyannopoulos P. Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 2014; 64:41– 51.
322.Grünig E, Peacock AJ. Imaging the heart in pulmonary hypertension: an update. Eur Respir Rev. 2015;24(138):653-64. Wright LM, Dwyer N, Celermajer D, Kritharides L, Marwick TH. Follow-Up of Pulmonary Hypertension With Echocardiography. JACC Cardiovasc Imaging. 2016; 9(6):733–746.
323.Wright LM, Dwyer N, Celermajer D, Kritharides L, Marwick TH. Follow-Up of Pulmonary Hypertension With Echocardiography. JACC Cardiovasc Imaging. 2016; 9(6):733–746.
324.Raymond R.J., Hinderliter A.L., Willis P.W., Ralph D., Caldwell E.J., Williams W., Ettinger N.A., Hill N.S., Summer W.R., de Boisblanc B., Schwartz T., Koch G., Clayton L.M., Jöbsis M.M., Crow J.W., Long W. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002; 39(7):1214–1219.
325.Sachdev A., Villarraga H.R., Frantz R.P., McGoon M.D., Hsiao J.F., Maalouf J.F., Ammash N.M., McCully R.B., Miller F.A., Pellikka P.A., Oh J.K., Kane G.C. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest. 2011; 139(6):1299–1309.
326.Peacock AJ, Vonk Noordegraaf A. Cardiac magnetic resonance imaging in pulmonary arterial hypertension. Eur Respir Rev. 2013; 22(130):526–534.
327.Baggen VJ, Leiner T, Post MC, van Dijk AP, Roos-Hesselink JW, Boersma E, Habets J, Sieswerda GT. Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Eur Radiol. 2016; 26(11):3771–3780.
328.Kang K., Chang H., Kim Y., Choi B., Lee H., Yang W., et al. Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension. Circ J. 2011; 75: 2244–2251
329.van Wolferen SA, Marcus JT, Boonstra A, Marques KMJ, Bronzwaer JGF, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A. Prognostic value of right ventricular mass,
145